Glaxo Sees 30% Slide in First-Quarter Profits

GlaxoSmithKline saw first-quarter profits slide 30%, a week after it announced a series of multibillion-dollar asset swaps with Novartis to bolster its consumer health and vaccines businesses.

Leave a Reply

Your email address will not be published. Required fields are marked *